Literature DB >> 9465619

[A case of fluorouracil-induced pneumonitis].

H Andou1, K Itoh, T Tsuda.   

Abstract

A 73-year-old man with colon cancer had been treated elsewhere for pneumonia on June 12, 1994. He was admitted to our hospital on June 21 with progressive dyspnea and bilateral diffuse infiltrates on chest X-ray. On admission, plain chest radiographs and chest CT scans revealed bilateral interstitial shadows predominantly in the outer zone, of the lower lobes. After an operation for rectal cancer, he had begun taking orally 300 mg of fluorouracil daily for 64 days. A drug lymphocyte stimulation test (DLST) was positive for fluorouracil. Fluorouracil-induced pneumonitis was subsequently diagnosed. To the best of our knowledge, there have been no previous case reports of fluorouracil-induced pneumonitis, and it seems likely that this pneumonitis resulted from both toxic and allergic reactions to the drug.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9465619

Source DB:  PubMed          Journal:  Nihon Kyobu Shikkan Gakkai Zasshi        ISSN: 0301-1542


  4 in total

1.  Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX).

Authors:  Katsuki Muneoka; Yoshio Shirai; Masataka Sasaki; Toshifumi Wakai; Jun Sakata; Katsuyoshi Hatakeyama
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

2.  Fatal pneumonitis induced by oxaliplatin: description of three cases.

Authors:  L B Pontes; D P D Armentano; A Soares; R C Gansl
Journal:  Case Rep Oncol       Date:  2012-02-29

Review 3.  Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient.

Authors:  Annick De Weerdt; Amélie Dendooven; Annemie Snoeckx; Jan Pen; Martin Lammens; Philippe G Jorens
Journal:  BMC Cancer       Date:  2017-08-29       Impact factor: 4.430

4.  A Rare Case of Irinotecan-induced Interstitial Pulmonary Disease and Diffuse Alveolar Hemorrhage in a Patient with Pancreatic Cancer.

Authors:  Lingbin Meng; Bo Deng; Baoqiong Liu; Umair Majeed; Wen Wang
Journal:  Cureus       Date:  2019-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.